Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22824
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaad, E. D.-
dc.contributor.authorBUYSE, Marc-
dc.date.accessioned2016-12-01T11:04:26Z-
dc.date.available2016-12-01T11:04:26Z-
dc.date.issued2016-
dc.identifier.citationANNALS OF ONCOLOGY, 27(8), p. 1653-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/1942/22824-
dc.description.abstract6. Yoon SH, Kim KW, Goo JM, Kim DW, Hahn S. Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer 2016; 53: 5-15. 7. Marten K, Auer F, Schmidt S et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur-
dc.language.isoen-
dc.publisherELSEVIER-
dc.rights© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.-
dc.titleResponse to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'-
dc.typeJournal Contribution-
dc.identifier.issue8-
dc.identifier.spage1653-
dc.identifier.volume27-
local.bibliographicCitation.jcatA1-
dc.description.notes[Saad, E. D.; Buyse, M.] Int Drug Dev Inst, Louvain La Neuve, Belgium. [Saad, E. D.] Dendrix Res, Sao Paulo, Brazil. [Buyse, M.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium.-
local.publisher.placeRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1093/annonc/mdw196-
dc.identifier.isi000383182800046-
local.provider.typePdf-
local.uhasselt.internationalyes-
item.accessRightsRestricted Access-
item.contributorSaad, E. D.-
item.contributorBUYSE, Marc-
item.validationecoom 2017-
item.fullcitationSaad, E. D. & BUYSE, Marc (2016) Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'. In: ANNALS OF ONCOLOGY, 27(8), p. 1653.-
item.fulltextWith Fulltext-
crisitem.journal.issn0923-7534-
crisitem.journal.eissn1569-8041-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1-s2.0-S0923753419347349-main.pdf
  Restricted Access		Published version52.6 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.